The hepatitis C virus alternate reading frame (ARF) and its family of novel products: The alternate reading frame protein/F-protein, the double-frameshift protein, and others

Seminars in Liver Disease

Volumn 25, Issue 1, 2005, Pages 105-117

  Branch, Andrea D ^a,b   Stump, Decherd D ^a   Gutierrez, Julio A ^a   Eng, Francis ^a   Walewski, José L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

Alternate reading frame; ARFP; Core; F protein; Frameshift; Hepatitis C

Indexed keywords

ALTERNATE READING FRAME PROTEIN; CORE PROTEIN; DOUBLE FRAMESHIFT PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VACCINE;

ALTERNATE READING FRAME; GENE EXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS GB VIRUS B; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; LIFE CYCLE; LIVER CANCER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RIBOSOMAL FRAMESHIFTING; RNA TRANSLATION; START CODON; STOP CODON; UPREGULATION; VIRUS CELL TRANSFORMATION; VIRUS GENOME;

ANIMALS; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS C; HUMANS; PROTEIN BIOSYNTHESIS; RNA, VIRAL; VIRAL CORE PROTEINS; VIRAL HEPATITIS VACCINES;

EID: 14644415892     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-864786     Document Type: Review

References (87)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA done derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362
2. Bradley DW, Cook EH, Maynard JE, et al. Experimental infection of chimpanzees with antihemophilic (factor VIII) materials: recovery of virus-like particles associated with non-A, non-B hepatitis. J Med Virol 1979;3:253-269
3. Choo Q, Richman KH, Han JH, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991;88:2451-2455
4. Lai MMC, Ware CF. Hepatitis C virus core protein: possible roles in viral pathogenesis. Curr Top Microbiol Immunol 2000;242:117-134
5. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996;70:4438-4443
6. Moriya K, Nakagawa K, Santa T, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001;61:4365-4370
7. Lerat H, Honda M, Beard MR, et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002;122:352-365
8. Hsieh TY, Matsumoto M, Chou HC, et al. Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleo-protein K. J Biol Chem 1998;273:17651-17659
9. Chang J, Yang SH, Cho YG, Hwang SB, Hahn YS, Sung YC. Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J Virol 1998;72:3060-3065
10. Jin DY, Wang HL, Zhou Y, et al. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J 2000;19:729-740
11. Tai DI, Tsai SL, Chen YM, et al. Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 2000;31:656-664
12. Lee S, Park U, Lee YI. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites. Virology 2001;283:167-177
13. Yoshida T, Hanada T, Tokuhisa T, et al. Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 2002;196:641-653
14. McLauchlan J. Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat 2000;7:2-14
15. Basu A, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology 2002;298:53-62
16. Delhem N, Sabile A, Gajardo R, et al. Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene 2001;20:5836-5845
17. Soguero C, Joo M, Chianese-Bullock KA, Nguyen DT, Tung K, Hahn YS. Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model. J Virol 2002;76:9345-9354
18. Dolganiuc A, Oak S, Kodys K, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 2004;127:1513-1524
19. Aguilar JC, Acosta-Rivero N, Duenas-Carrera S, et al. HCV core protein modulates the immune response against the HBV surface antigen in mice. Biochem Biophys Res Commun 2003;310:59-63
20. Eisen-Vandervelde AL, Waggoner SN, Yao ZQ, Cale EM, Hahn CS, Hahn YS. Hepatitis C virus core selectively suppresses interleukin-12 synthesis in human macrophages by interfering with AP-1 activation. J Biol Chem 2004;279:43479-43486
21. Erhardt A, Hassan M, Heintges T, Haussinger D. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 tet-off cell line. Virology 2002;292:272-284
22. Brown EA, Zhang H, Ping LH, Lemon SM. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res 1992;20:5041-5045
23. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J Virol 1992;66:1476-1483
24. Wang C, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol 1993;67:3338-3344
25. Spahn CM, Kieft JS, Grassucci RA, et al. Hepatitis C virus IRES RNA-induced changes in the conformation of the 40s ribosomal subunit. Science 2001;291:1959-1962
26. Kolykhalov AA, Feinstone SM, Rice CM. Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J Virol 1996;70:3363-3371
27. Kolykhalov AA, Mihalik K, Feinstone SM, Rice CM. Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo. J Virol 2000;74:2046-2051
28. Walewski JL, Stump DD, Keller TR, Branch AD. HCV patients have antibodies against a novel protein encoded in a second reading frame. Hepatology 1998;28: 278A
29. Walewski JL, Keller TR, Stump DD, Branch AD. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 2001;7:710-721
30. Xu Z, Choi J, Yen TS, et al. Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 2001;20:3840-3848
31. Vassilaki N, Mavromara P. Two alternative translation mechanisms are responsible for the expression of the HCV ARFP/F/core + 1 coding open reading frame. J Biol Chem 2003;278:40503-40513
32. Boulant S, Becchi M, Penin F, Lavergne JP. Unusual multiple recoding events leading to alternative forms of hepatitis C virus core protein from genotype 1b. J Biol Chem 2003;278:45785-45792
33. Komurian-Pradel F, Rajoharison A, Berland JL, et al. Antigenic relevance of F protein in chronic hepatitis C virus infection. Hepatology 2004;40:900-909
34. Miladi A, Lavergne J, Hezode C, Dhumeaux D, Penin F, Pawlotsky JM. Prevalence of anti-HCV F (frameshift) protein antibodies in patients with various forms of HCV infection and the putative physiological role of F protein. Paper presented at: 11th International Symposium on Hepatitis C Virus and Related Viruses, abstract P-257; October 3-7, 2004, in Heidelberg, Germany
35. Bain C, Parroche P, Lavergne JP, et al. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection. J Virol 2004;78:10460-10469
36. Ina Y, Mizokami M, Ohba K, Gojobori T. Reduction of synonymous substitutions in the core protein gene of hepatitis C virus. J Mol Evol 1994;38:50-56
37. Smith DB, Simmonds P. Characteristics of nucleotide substitutions in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol 1997;45:238-246
38. Walewski JL, Gutierrez JA, Branch-Elliman W, et al. Mutation master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA 2002;8:557-571
39. James BD, Olsen GJ, Pace NR. Phylogenetic comparative sequence analysis of RNA secondary structure. Methods Enzymol 1989;180:227-239
40. James BD, Olsen GJ, Pace NR. Phylogenic comparative analysis of RNA secondary structure. Methods Enzymol 1989;180:227-239
41. Zuker M, Stiegler P. Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information. Nucleic Acids Res 1981;9:133-148
42. You SY, Stump DD, Branch AD, Rice CM. A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication. J Virol 2004;78:1352-1366
43. Lee H, Shin H, Wimmer E, Paul AV. cis-Acting RNA signals in the NS5B C-terminal coding sequence of the hepatitis C virus genome. J Virol 2004;78:10865-10877
44. Friebe P, Boudet J, Dimorre JP, Bartenschlager R. A kissing loop interaction between a novel cis acting RNA element in the NS5b coding region and the 3′ non-translated region is required for hepatitis C virus RNA replication. Paper presented at: 11th International Symposium on Hepatitis C Virus and Related Viruses, abstract 0-17; October 3-7, 2004, in Heidelberg, Germany
45. Gesteland RF, Weiss RB, Atkins JF. Recoding: reprogrammed genetic decoding. Science 1992;257:1640-1641
46. Matsufuji S, Matsufuji T, Miyazaki Y, et al. Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell 1995;80:51-60
47. Ivanov IP, Gesteland RF, Atkins JF. A second mammalian antizyme: conservation of programmed ribosomal frameshifting. Genomics 1998;52:119-129
48. Weiss RB, Dunn DM, Dahlberg AE, Atkins JF, Gesteland RF. Reading frame switch caused by base-pair formation between the 3′ end of 16S rRNA and the mRNA during elongation of protein synthesis in Escherichia coli. EMBO J 1988;7:1503-1507
49. Dulude D, Baril M, Brakier-Gingras L. Characterization of the frameshift stimulatory signal controlling a programmed -1 ribosomal frameshift in the human immunodeficiency virus type 1. Nucleic Acids Res 2002;30:5094-5102
50. Varaklioti A, Vassilaki N, Georgopoulou U, Mavromara P. Alternate translation occurs within the core coding region of the hepatitis C viral genome. J Biol Chem 2002;277:17713-17721
51. Gosert R, Moradpour D. Reading between the lines: evidence for a new hepatitis C virus protein. Hepatology 2002;36:757-760
52. Choi J, Xu Z, Ou Jh. Triple decoding of hepatitis C virus RNA by programmed translational frameshifting. Mol Cell Biol 2003;23:1489-1497
53. Roussel J, Pillez A, Montpellier C, et al. Characterization of the expression of the hepatitis C virus F protein. J Gen Virol 2003;84:1751-1759
54. Basu A, Meyer K, Ray RB, Ray R. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocytes. Virology 2002;298:53-62
55. Lo SY, Masiarz F, Hwang SB, Lai MM, Ou JH. Differential subcellular localization of hepatitis C virus core gene products. Virology 1995;213:455-461
56. Lo SY, Selby M, Tong M, Ou JH. Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution. Virology 1994;199:124-131
57. Xu Z, Choi J, Lu W, Ou JH. Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum. J Virol 2003;77:1578-1583
58. Wolf M, Dimitrova M, Kien F, Schuster C. Translocation of the hepatitis C virus F protein sequence: influence of the RNA context and of the presence of HCV proteins. Paper presented at: 11th International Symposium on Hepatitis C Virus and Related Viruses, abstract P-84; October 3-7, 2004, in Heidelberg, Germany
59. Vassilaki N, Mavromara P. Expression studies on the short form of the HCV ARFP/F/core + 1 protein in mammalian cells. Paper presented at: 11th International Symposium on Hepatitis C Virus and Related Viruses, abstract 0-25; October 3-7, 2004, in Heidelberg, Germany
60. Ganem D. Virology. The X files - one step closer to closure. Science 2001;294:2299-2300
61. Lohmann V, Korner F, Koch JO, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999;285:110-113
62. Blight KJ, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science 2000;290:1972-1974
63. McMulllan LK, Grakoui A, Puig M, et al. Multiple stop codons in the HCV ARF suggest that expression of F/ARFP is not essential for virus replication but reveal a functional RNA element. Paper presented at: 11th International Symposium on Hepatitis C Virus and Related Viruses, abstract 0-20; October 3-7, 2004, in Heidelberg, Germany
64. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41-63
65. Shimizu I, Yao D-F, Horie C, et al. Mutations in a hydrophilic part of the core gene of hepatitis C virus in patients with hepatocellular carcinoma in China. J Gastroenterol 1997;32:47-55
66. Takahashi K, Iwata K, Matsumoto M, et al. Hepatitis C virus (HCV) genotype 1b sequences from fifteen patients with hepatocellular carcinoma: the 'progression score' revisited. Hepatol Res 2001;20:161-171
67. Hayashi J, Furusyo N, Ariyama I, Sawayama Y, Etoh Y, Kashiwagi S. A relationship between the evolution of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients with hepatitis C viremia. J Infect Dis 2000;181:1523-1527
68. Ruster B, Zeuzem S, Krump-Konvalinkova V, et al. Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue. J Med Virol 2001;63:128-134
69. Alam SS, Nakamura T, Naganuma A, et al. Hepatitis C virus quasispecies in cancerous and noncancerous hepatic lesions: the core protein-encoding region. Acta Med Okayama 2002;56:141-147
70. Ogata S, Nagano-Fujii M, Ku Y, Yoon S, Hotta H. Comparative sequence analysis of the core protein and its frameshift product, the F protein, of hepatitis C virus subtype 1b strains obtained from patients with and without hepatocellular carcinoma. J Clin Microbiol 2002;40:3625-3630
71. Yeh CT, Lo SY, Dai DI, Tang JH, Chu CM, Liaw YF. Amino acid substitutions in codons 9-11 of hepatitis C virus core protein lead to the synthesis of a short core protein product. J Gastroenterol Hepatol 2000;15:182-191
72. Rullier A, Trimoulet P, Urbaniak R, et al. Immunohistochemical detection of HCV in cirrhosis, dysplastic nodules, and hepatocellular carcinomas with parallel-tissue quantitative RT-PCR. Mod Pathol 2001;14:496-505
73. Branch AD, Walewski JL, Gutierrez JA, et al. HCV alternate reading frame proteins (ARFPs) may be virulence factors that help the virus survive adverse conditions. Hepatology 2003;38:468A-469A
74. Honda M, Kaneko S, Matsushita E, Kobayashi K, Abell GA, Lemon SM. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation. Gastroenterology 2000;118:152-162
75. Pietschmann T, Lohmann V, Rutter G, Kurpanek K, Bartenschlager R. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs. J Virol 2001;75:1252-1264
76. Basu A, Steele R, Ray R, Ray RB. Functional properties of a 16 kDa protein translated from an alternative open reading frame of the core-encoding genomic region of hepatitis C virus. J Gen Virol 2004;85:2299-2306
77. Griffin SV, Shankland SJ. Not just an inhibitor: a role for p21 beyond the cell cycle - The truth is rarely pure and never simple. J Am Soc Nephrol 2004;15:825-826
78. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol 2003;13:65-70
79. Shou J, Soriano R, Hayward SW, Cunha GR, Williams PM, Gao WQ. Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci USA 2002;99:2830-2835
80. Kulaeva OI, Draghici S, Tang L, Kraniak JM, Land SJ, Tainsky MA. Epigenetic silencing of multiple interferon pathway genes after cellular immortalization. Oncogene 2003;22:4118-4127
81. Zhang X, Chatel L, Fournillier A, et al. Vaccine induced immune responses specific of the Alternate Reading Frame Protein (ARFP) of HCV. Paper presented at: 11th International Symposium on Hepatitis C Virus and Related Viruses, abstract 0-68; October 3-7, 2004, in Heidelberg, Germany
82. Malarkannan S, Horng T, Shih PP, Schwab S, Shastri C. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 1999;10:681-690
83. Cardinaud S, Moris A, Fevrier M, et al. Identification of cryptic MCHI-restricted epitopes encoded by HIV-1 alternate reading frames. J Exp Med 2004;199:1053-1063
84. André P, Perlemuter G, Budkowska A, Bréchot C, Lotteau V. Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 2005;25:93-104
85. Tillmann HL, Manns MP, Rudolph KL. Merging models of hepatitis C virus pathogenesis. Semin Liver Dis 2005;25:84-92
86. Heller T, Rehermann B. Acute hepatitis C: A multifaceted disease. Semin Liver Dis 2005;25:7-17
87. Morgello S. The nervous system and hepatitis C virus. Semin Liver Dis 2005;25:118-121